Price T Rowe Associates Inc Spring Works Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,516,418 shares of SWTX stock, worth $125 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,516,418

Previous 3,602,234 2.38%

Holding current value

$125 Million

Previous $136 Million 16.97%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.04 - $42.76 $2.75 Million - $3.67 Million	-85,816 Reduced 2.38%	3,516,418 $113 Million
Q2 2024 Aug 14, 2024	SELL	$36.06 - $47.62 $18.3 Million - $24.2 Million	-508,228 Reduced 12.36%	3,602,234 $136 Million
Q1 2024 May 15, 2024	BUY	$36.5 - $52.5 $48.7 Million - $70 Million	1,333,892 Added 48.04%	4,110,462 $202 Million
Q4 2023 Feb 14, 2024	BUY	$18.94 - $37.24 $23.1 Million - $45.5 Million	1,221,056 Added 78.5%	2,776,570 $101 Million
Q3 2023 Nov 14, 2023	BUY	$23.12 - $31.38 $4.97 Million - $6.74 Million	214,884 Added 16.03%	1,555,514 $36 Million
Q2 2023 Aug 14, 2023	BUY	$23.15 - $32.71 $24.7 Million - $34.9 Million	1,067,203 Added 390.31%	1,340,630 $35.2 Million
Q1 2023 May 15, 2023	BUY	$24.97 - $34.05 $868,306 - $1.18 Million	34,774 Added 14.57%	273,427 $7.04 Million
Q4 2022 Feb 14, 2023	SELL	$21.73 - $28.72 $221,689 - $293,001	-10,202 Reduced 4.1%	238,653 $6.21 Million
Q3 2022 Nov 14, 2022	BUY	$24.1 - $39.66 $178,629 - $293,959	7,412 Added 3.07%	248,855 $7.1 Million
Q2 2022 Aug 15, 2022	SELL	$18.36 - $60.07 $1.36 Million - $4.45 Million	-73,999 Reduced 23.46%	241,443 $5.94 Million
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $166,546 - $222,629	3,401 Added 1.09%	315,442 $17.8 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $246,992 - $351,442	4,634 Added 1.51%	312,041 $19.3 Million
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $95,869 - $135,037	-1,530 Reduced 0.5%	307,407 $19.5 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $1.26 Million - $1.6 Million	-18,742 Reduced 5.72%	308,937 $25.5 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $97,584 - $140,291	1,499 Added 0.46%	327,679 $24.1 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $15.8 Million - $25.4 Million	326,180 New	326,180 $23.7 Million

Others Institutions Holding SWTX

# of Institutions

237

Shares Held

68.9M

Call Options Held

144K

Put Options Held

257K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.22B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Spring Works Therapeutics, Inc. Transaction History